Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.
Amy M. Egras, PharmD, BCPS
Advertisement
Articles by Amy M. Egras, PharmD, BCPS
Advertisement
Latest Updated Articles
- Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide
Published: April 27th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
4
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
5
